Founded in 2004, Direct Flow Medical, Inc. is a privately-held, emerging medical device company focused on next generation, transcatheter technologies to treat patients with heart disease. Its devices are designed to improve patient outcomes while reducing complications. The Company is headquartered in Santa Rosa, California, with technology and manufacturing facilities in Lake Forest, California. The Company's proprietary technology is not limited to aortic valve disease, and is readily applicable to mitral and other heart valve anatomical sites. Direct Flow Medical investors include EDF Ventures, New Leaf Venture Partners, Spray Venture Partners, Foundation Medical Partners, SV Life Sciences, VantagePoint Venture Partners, ePlanet Venture Partners and strategic corporate investors.